The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.
Copyright 2025 NPR
The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.
Copyright 2025 NPR
The biggest portion of Boise State Public Radio's funding comes from readers like you who value fact-based journalism and trustworthy information.
Your donation today helps make our local reporting free for our entire community.